CEFTRIAXONE ALPHAPHARM ceftriaxone (as sodium) 500 mg powder for injection vial

দেশ: অস্ট্রেলিয়া

ভাষা: ইংরেজি

সূত্র: Department of Health (Therapeutic Goods Administration)

সক্রিয় উপাদান:

ceftriaxone sodium

থেকে পাওয়া:

Alphapharm Pty Ltd

INN (আন্তর্জাতিক নাম):

ceftriaxone sodium

অনুমোদন অবস্থা:

Registered

পণ্য বৈশিষ্ট্য

AUSTRALIAN PRODUCT INFORMATION
CEFTRIAXONE ALPHAPHARM
_Ceftriaxone sodium powder for injection _
1
NAME OF THE MEDICINE
Ceftriaxone sodium
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each Ceftriaxone Alphapharm powder for injection vial contains
ceftriaxone sodium equivalent to either 250
mg, 500 mg, 1000 mg or 2000 mg of ceftriaxone as a single ingredient.
Ceftriaxone sodium contains approximately 83 mg (3.6 mEq) of sodium
per gram of ceftriaxone activity.
The product contains no excipients or preservatives.
3
PHARMACEUTICAL FORM
Ceftriaxone Alphapharm
1000 mg
:
For intramuscular injection. For intravenous injection and infusion.
A white to slightly yellow crystalline powder for injection vial.
Ceftriaxone Alphapharm
2000 mg
:
For intravenous infusion.
A white to slightly yellow crystalline powder for injection vial.
Ceftriaxone Alphapharm
250 mg
:
For intramuscular injection. For intravenous injection and infusion.
A white to slightly yellow crystalline powder for injection vial.
Ceftriaxone Alphapharm
500 mg
:
For intramuscular injection. For intravenous injection and infusion.
A white to slightly yellow crystalline powder for injection vial.
The colour of ceftriaxone sodium solutions ranges from light yellow to
amber, depending on the length of
storage, concentration and diluent used.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Ceftriaxone Alphapharm is indicated for the treatment of the following
infections when caused by susceptible
aerobic organisms:
•
LOWER RESPIRATORY TRACT INFECTIONS: caused by
_S. pneumoniae_
, Streptococcus species
(excluding enterococci), methicillin sensitive
_S. aureus, H. influenzae, H. parainfluenzae_
, Klebsiella
species (including
_K. pneumoniae_
),
_E. coli_
,
_E. aerogenes_
,
_Proteus mirabilis_
and
_Serratia marcescens_
.
•
SKIN
AND
SKIN
STRUCTURE
INFECTIONS:
caused
by
methicillin
sensitive
_S. _
_aureus_
,
methicillin sensitive
_S. epidermidis_
, Streptococcus Group B, Streptococcus Group G,
_Streptococcus _
_pyogenes, Streptococcus viridans_
, Streptococcus speci